First-line #sintilimab plus #platinum-etoposide is effective and safe in #ESSCLC, with multi-omics analyses revealing local and systemic #ImmuneLandscapes, enabling the construction of a non-invasive #biomarker model. #medsky
#STTT #OpenAccess: doi.org/10.1038/s413...
0
0
0
0